| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3847812 | American Journal of Kidney Diseases | 2014 | 8 Pages |
Abstract
Hepatic TAE appears to be a safe and less invasive option for patients with symptomatic polycystic liver, especially those contraindicated for surgical treatment (eg, with malnutrition or on dialysis therapy), improving both hepatic volume and nutrition.
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
Junichi MD, MPH, Yoshifumi MD, PhD, Tatsuya MD, Keiichi MD, Noriko MD, Koki MD, Rikako MD, Eiko MD, Masayuki MD, Naoki MD, Ryoji MD, Kenmei MD, PhD,